了解状细胞特征患者体外膜氧气支持的结果
Kate M Willsey1, Michael E Plazak2, Leonid Belyayev3
1University of Maryland School of Medicine, Baltimore, MD.
Critical care explorations
|September 30, 2025
概括
与状细胞病 (SCD) 患者相比,需要体外膜氧化 (ECMO) 的状细胞特征 (SCT) 患者的存活率较好. 对于SCT患者来说,ECMO似乎是安全的,尽管需要进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
- 支持心肺血管的支持.
背景情况:
- 血球蛋白病,包括状细胞特征 (SCT) 和状细胞疾病 (SCD),是常见的遗传血液疾病.
- 在接受体外膜氧化 (ECMO) 的成年人中,SCT对结果的影响尚不清楚.
- 现有的研究往往忽略或低估了SCT在患者群体中的患病率.
研究的目的:
- 评估SCT和SCD接受静脉动脉 (VA) 或静脉 (VV) ECMO的成年患者的结果.
- 为了比较SCT和SCD患者之间的生存率,并发症概况和ECMO治疗的安全性.
- 评估ECMO患者队列中SCT的流行率.
主要方法:
- 对体外生命支持组织 (ELSO) 注册数据的分析.
- 包括接受VA或VVECMO的成年患者.
- 基于SCT和SCD状态的患者的识别和分层.
- 根据年龄调整的生存率和并发症率 (出血,血栓,脏问题) 的比较.
主要成果:
- 总共分析了215名患者:49名SCT和166名SCD.
- 发现SCT的患病率高于之前的假设.
- 对SCT患者的年龄调整后生存率明显优于VA-ECMO的SCD患者 (43.5%对19.5%; p=0.04) ,并且对VV-ECMO (73.3%对44.8%; p=0.11) 有更好的趋势.
- 在SCT和SCD患者中,出血,血栓事件和并发症在SCT和SCD患者之间是相似的,并且与一般ECMO人群相似.
结论:
- 体外膜氧化 (ECMO) 可以安全地用于患有状细胞特征 (SCT) 的成年患者.
- 与状细胞疾病 (SCD) 患者相比,SCT患者在ECMO上表现出更有利的结果.
- 需要进一步的研究,以充分阐明血红蛋白病对ECMO治疗和患者结果的临床影响.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.3K
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
589
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
589
Oxygen Transport in the Blood
6.0K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
6.0K
Acute Respiratory Failure-V
462
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
462
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
1.9K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
1.9K
